PROGRESS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PURPOSES

Recombinant human serum albumin (OsrHSA) has emerged as a major innovation in the field of biopharmaceuticals, presenting promising advancements throughout a variety of healthcare and industrial programs. With its structural similarity to Obviously derived human serum albumin, OsrHSA offers a safer, much more trustworthy substitute for therapeutic